Cancer News and Research

Latest Cancer News and Research

Twice as many people as previously thought are dying from sepsis, says new report

A new analysis presented at the Critical Care Reviews annual meeting in Belfast, has found that the number of people dying from sepsis worldwide is twice as high as previously estimated.

16 Jan 2020

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

A stem cell transplant - also called a bone marrow transplant - is a common treatment for blood cancers, such as acute myeloid leukemia.

16 Jan 2020

OU collaborates with Peruvian University to develop $9 million joint research program

The University of Oklahoma has entered an agreement to develop a $9 million program of joint research with Universidad Nacional de San Agustin, one of Peru's largest and oldest public research universities.

16 Jan 2020

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Oxford Gene Technology, A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing offering for research into Chronic Lymphocytic Leukaemia.

From Oxford Gene Technology 16 Jan 2020

B cell count tells how certain cancers will respond to immunotherapy

Some melanomas, sarcomas and renal cell carcinomas, but not all, have been found to respond dramatically to new drugs called immune checkpoint blockers, which exploit the body’s known capability to mount an immune response against the foreign antigen-bearing tumor cells.

15 Jan 2020

Bladder cancer linked to drinking water chemicals in Europe

Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.

15 Jan 2020

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Researchers at Mount Sinai School of Medicine say the immune system might contribute to the tumor heterogeneity seen in liver cancer that can affect the rate of cancer growth.

15 Jan 2020

Nicoya gains series A funding for digital drug discovery program

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing.

From Nicoya Lifesciences 15 Jan 2020

Tips to prevent acne caused by workouts

Those hitting the gym on account of their New Year's resolutions are likely reaping the benefits, including improved overall health and mood.

14 Jan 2020

Unique tool to democratize entry into the field of nanopore research

A nanopore is a tiny hole in a thin membrane with a diameter of around a billionth of a meter, or about the width of a single DNA molecule.

14 Jan 2020

Number of operations performed in a hospital linked to success of cancer surgery

Tumors of the colon, so-called colorectal carcinomas, are the second to third most frequent tumors in women and men in Germany. The surgical removal of the tumors is a central component of the therapy.

14 Jan 2020

Princeton researchers uncover vital role played by a protein elevated in many cancers

Researchers at Princeton University have successfully recreated a key process involved in cell division in a test tube, uncovering the vital role played by a protein that is elevated in over 25% of all cancers.

14 Jan 2020

WHO spells out most urgent health issues for the next 10 years

The World Health Organization (WHO) has released its “to-do” list of the most urgent worldwide health issues that need to be tackled over the next decade. The heart of the issue, argues the WHO, is that governments are simply failing to fund health needs and health care systems. As a result, they are putting many people at the risk of death, poverty and of a national economic downturn.

14 Jan 2020

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer.

14 Jan 2020

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Study shows how treatment resistance develops in patients with bile duct cancer

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows how resistance to a promising targeted drug develops in patients with a rare, lethal cancer of the bile ducts called cholangiocarcinoma.

14 Jan 2020

Rapid diagnosis centers cut waiting times for patients with non-specific symptoms

A rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than current usual care if used at more than 80% of capacity, a new study by Swansea University researchers and NHS colleagues has shown.

14 Jan 2020

Cancer News and Research

Latest Cancer News and Research

Twice as many people as previously thought are dying from sepsis, says new report

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

OU collaborates with Peruvian University to develop $9 million joint research program

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

B cell count tells how certain cancers will respond to immunotherapy

Bladder cancer linked to drinking water chemicals in Europe

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Nicoya gains series A funding for digital drug discovery program

Tips to prevent acne caused by workouts

Unique tool to democratize entry into the field of nanopore research

Number of operations performed in a hospital linked to success of cancer surgery

Princeton researchers uncover vital role played by a protein elevated in many cancers

WHO spells out most urgent health issues for the next 10 years

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

Biomaterial-based vaccine has potential to completely eliminate AML cells

Study shows how treatment resistance develops in patients with bile duct cancer

Rapid diagnosis centers cut waiting times for patients with non-specific symptoms

Skin-protecting antibody may promote tumor growth during chronic tissue inflammation

Bath scientists identify promising route to develop new treatments for skin cancer

Study shows how cancer-causing genes promote metastasis

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in